Smartleaf Asset Management
IMNM icon

Smartleaf Asset Management’s Immunome IMNM Stock Holding History

Smartleaf Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$810 Sell
37
-145
-80% -$3.6K ﹤0.01% 3254
2026
Q2 		$3.83K Hold
182
– – ﹤0.01% 2769
2026
Q1 		$3.51K Buy
+182
New +$4.05K ﹤0.01% 2790

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Alerus Financial
Alerus Financial Grand Forks, North Dakota $2.27B AUM 22.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Smartleaf Asset Management's IMNM Position: Q3 2026 in Review

Smartleaf Asset Management reduced its Immunome (IMNM) stake by 80% in Q3 2026, selling an estimated $3.6K and leaving 37 shares worth $810. The position accounts for ﹤0.01% of the portfolio, ranked #3254.

Smartleaf Asset Management first reported a position in IMNM in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.83K in Q2 2026. 84 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

  • Smartleaf Asset Management held 37 shares of Immunome worth $810 as of Q3 2026.
  • Smartleaf Asset Management sold 145 Immunome shares in Q3 2026, an estimated $3.6K.
  • Immunome made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3254 holding.
  • Smartleaf Asset Management first reported a position in Immunome in Q1 2026 and has held it in 3 quarters since.
  • Smartleaf Asset Management's Immunome position peaked at $3.83K in Q2 2026.
  • 84 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.